Odyssey Evaluation in Post LASIK Patients (NCT07260695) | Clinical Trial Compass
RecruitingPhase 4
Odyssey Evaluation in Post LASIK Patients
United States30 participantsStarted 2025-08-18
Plain-language summary
This prospective study evaluates the visual and refractive outcomes of the TECNIS Odyssey intraocular lens (IOL) implanted in patients with a history of myopic LASIK. Given the unique optical challenges of post-LASIK eyes, including altered corneal curvature and higher-order aberrations, the study aims to assess the IOL's performance in terms of distance, intermediate, and near vision, and patient satisfaction. Its design features may offer favorable outcomes in these patients.
Who can participate
Age range50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age: 50 years and older.
✓. Gender: Males and Females.
✓. Bilateral cataracts
✓. Bilateral implantation of Odyssey IOLs (toric and non-toric)
✓. Scheduled to undergo standard cataract surgery in both eyes, within 1 to 30 days between surgeries.
✓. Willing and able to provide written informed consent for participation in the study.
✓. Willing and able to comply with scheduled visits and study examination procedures.
✓. Postoperative best corrected visual acuity of 0.2 logMAR (20/32 Snellen) or better in each eye.
Exclusion criteria
✕. Established ocular pathology, including: glaucoma (except glaucoma suspects), uveitis, and clinically-significant retinal pathology affecting the macula (with visual acuity worse than 20/25) and/or any other ocular findings that may, in the opinion of the investigator, affect vision.
✕. Uncontrolled diabetes.
✕. Use of any systemic or topical drug known to interfere with visual performance.
✕. Any concurrent infectious/non-infectious conjunctivitis, keratitis or uveitis.